by charles.henry.dion@iktos.com | Mar 5, 2024 | PR
Iktos and Elsevier partner to deliver a predictive retrosynthesis and synthetic accessibility platform. Combining the world’s largest chemistry database, Reaxys from Elsevier, with cutting-edge AI from Iktos, the advanced platform will enable pharmaceutical companies...
by charles.henry.dion@iktos.com | Feb 14, 2024 | PR
Iktos announces the opening of its subsidiary in Japan and entrusts its management to Hideyoshi Fuji as Representative Director of Iktos K.K., and Vice-President, Japan Business Development and Operations. Follow the link for the full press...
by Payash Bahuguna | Jan 18, 2024 | PR
Iktos announces the appointment of Avirup Bose as Chief Business Officer. At Iktos, Avirup will lead the global business development team to drive business strategy. He will also be a member of the executive committee and will work together to develop the company...
by Payash Bahuguna | Jan 8, 2024 | PR
Iktos and Nerviano Medical Sciences S.r.l (NMS), a leading Italian clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, announced a collaboration agreement in AI for unprecedented kinase project. As per the agreement, NMS...
by Payash Bahuguna | Dec 14, 2023 | PR
Iktos and Bayer’s Crop Science division with its industry-leading R&D pipeline and portfolio of seeds & traits, crop protection and digital farming solutions, today announced a collaboration to expand the use of AI in the discovery and development of new...
by Payash Bahuguna | Sep 29, 2023 | PR
We are thrilled to announce that Iktos has won the “Big Data & AI for Good” prize at the 12th edition of the Big Data & AI Paris Congress on 25th September. We are very honoured to be recognized for our innovation in serving the general interest....